panitumumab,bevacizumab
takeda,roche,amgen
['bevacizumab', 'lba21', 'panitumumab', 'cairo5', 'rectal', 'colorectal']
intriguing late breaking abstract at #esmo2022: #folfox /#folfiri + #bevacizumab or #panitumumab in #crlm and ras/brafv600e wt tumour: phase iii #cairo5 study, dutch colorectal cancer group! 11/09/2022, 10:15 lba21 #meded 
Independent and international experts in GI oncology supporting medical oncologists to give the best possible care to patients. Part of https://t.co/Y8pV8OaxOB